🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jill Buck

ORCID: 0000-0003-4129-3092

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial”.

Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial

Neuro-Oncology(2021)10.1093/neuonc/noab271

N/A

2.4DataRank · unranked

110 citations

Arnold B. Gelb, Clark C. Chen, Ganesh Rao, David A. Reardon, Patrick Y. Wen +19 more

Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease

NeuroImage(2022)10.1016/j.neuroimage.2022.119228

N/A

1.6DataRank · unranked

69 citations

Patrick H. Luckett, Brian A. Gordon, Tammie L.S. Benzinger, Suzanne E. Schindler, Anne M. Fagan +87 more

Association ofBDNFVal66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease

JAMA Neurology(2022)10.1001/jamaneurol.2021.5181

N/A

1.2DataRank · unranked

37 citations

Paul Maruff, Nicolas R. Barthélemy, Alison Goate, Jason Hassenstab, Chihiro Sato +87 more

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

The Lancet Neurology(2022)10.1016/s1474-4422(22)00408-2

N/A

1.1DataRank · unranked

56 citations

Brian A. Gordon, Julie K. Wisch, Shaney Flores, Rachel L. Henson, Omar H. Butt +95 more

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study

The Lancet Neurology(2022)10.1016/s1474-4422(22)00027-8

N/A

0.774DataRank · unranked

173 citations

Yan Li, Brigitte Nuscher, Nicolai Franzmeier, Chengjie Xiong, Marc Suárez-Calvet +95 more

Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer’s disease

Brain(2023)10.1093/brain/awac498

N/A

0.515DataRank · unranked

30 citations

Jeremy F. Strain, Patricia K. Mansfield, Jiaxin Cindy Tu, Aaron Tanenbaum, Oliver Preische +85 more

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease

Brain Communications(2020)10.1093/braincomms/fcaa102

N/A

0.464DataRank · unranked

21 citations

Ellen Dicks, Guoqiao Wang, Aylin Dincer, Shaney Flores, Sarah Keefe +81 more

Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s disease

Alzheimer s Research & Therapy(2025)10.1186/s13195-024-01659-6

N/A

0.406DataRank · unranked

14 citations

Andrew B. Caldwell, Qing Liu, Michael Q. Fitzgerald, Srinivasan Ramachandran, Celeste M. Karch +95 more

Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab045

N/A

0.378DataRank · unranked

7 citations

Rimas V. Lukas, Christina Amidei, Nathan Demars, Arnold B. Gelb, Jill Buck +8 more